Gonadorelin injection 2mg 5mg 10mg cas 9034-40-6

Gonadorelin (GnRH) is a ten-amino acid peptide and a potent agonist of gonadotropin-releasing hormone. Its main function is to stimulate the synthesis and release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). In human medicine, it finds application in treating infertility, menstrual cycle irregularities, and hypogonadism. Additionally, it serves as a valuable diagnostic tool for assessing pituitary function.

Exciting ongoing research has uncovered promising potential uses for gonadorelin in the treatment of breast and prostate cancer, as well as in addressing Alzheimer’s disease. These findings open up new possibilities for the therapeutic application of gonadorelin in diverse medical contexts.

Gonadorelin Structure

Sequence: Pyr-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly
Molecular Formula: C55H75N17O13
Molecular Weight: 1182.311 g/mol
PubChem CID: 638793
CAS Number: 9034-40-6
Synonyms: Growth Hormone Releasing Factor, Somatocrinin, Somatoliberin

Gonadorelin Effects

• Gonadorelin Research and Breast Cancer Prevention
• Gonadorelin a Breakthrough in Prostate Cancer
• Gonadorelin May Reduce Dementia Risk

Other peptide list